Introduction
Hemophilia B (Factor IX Deficiency) - Overview
Hemophilia B (Factor IX Deficiency) - Therapeutics Development
Hemophilia B (Factor IX Deficiency) - Therapeutics Assessment
Hemophilia B (Factor IX Deficiency) - Companies Involved in Therapeutics Development
Hemophilia B (Factor IX Deficiency) - Drug Profiles
Hemophilia B (Factor IX Deficiency) - Dormant Projects
Hemophilia B (Factor IX Deficiency) - Discontinued Products
Hemophilia B (Factor IX Deficiency) - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Hemophilia B (Factor IX Deficiency), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by ApcinteX Ltd, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by ASC Therapeutics Inc, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by Catalyst Biosciences Inc, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by Chengdu Rongsheng Pharmaceutical Co Ltd, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by Daiichi Sankyo Co Ltd, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by Expression Therapeutics LLC, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by Freeline Therapeutics Ltd, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by GC Pharma, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by Genzyme Corp, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by Intellia Therapeutics Inc, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by LFB SA, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by Logicbio Therapeutics Inc, H2 2020
Hemophilia B (Factor IX Deficiency) - Pipeline by Novo Nordisk AS, H2 2020
Hemophilia B (Factor IX Deficiency) - Dormant Projects, H2 2020
Hemophilia B (Factor IX Deficiency) - Discontinued Products, H2 2020

List of Figures
Number of Products under Development for Hemophilia B (Factor IX Deficiency), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020

Companies Mentioned
• ApcinteX Ltd
• ASC Therapeutics Inc
• Catalyst Biosciences Inc
• Chengdu Rongsheng Pharmaceutical Co Ltd
• Daiichi Sankyo Co Ltd
• Expression Therapeutics LLC
• Freeline Therapeutics Ltd
• GC Pharma
• Genzyme Corp
• Intellia Therapeutics Inc
• LFB SA
• Logicbio Therapeutics Inc
• Novo Nordisk AS
• OPKO Health Inc
• Pfizer Inc
• RegenxBio Inc
• Sangamo Therapeutics Inc
• Sanofi
• Shenzhen Weiwu Guangming Biological Preparations Co Ltd
• Sigilon Therapeutics Inc
• Staidson BioPharma Inc
• Takeda Pharmaceutical Co Ltd
• UBI Pharma Inc
• UniQure NV